膀胱癌尿液外泌體lncRNA診斷模型的建立及對膀胱癌復(fù)發(fā)監(jiān)測的臨床意義
發(fā)布時間:2021-11-28 18:27
目的:近年來有研究發(fā)現(xiàn)膀胱癌細(xì)胞可以分泌外泌體(exosomes)進(jìn)入尿液中,并與癌癥的進(jìn)展有關(guān)。外泌體中含有致癌長鏈非編碼RNA(lncRNAs)分子,其表達(dá)水平可反映腫瘤的動態(tài)變化。因此,尿液外泌體中差異表達(dá)的lncRNA分子可作為膀胱癌診斷和預(yù)后的新型非侵入性生物標(biāo)志物。本研究的目的是提取并鑒定尿液外泌體,分析其lncRNA分子表達(dá)譜;構(gòu)建尿液外泌體lncRNA診斷模型用于膀胱癌診斷,并探究尿液外泌體lncRNA分子與膀胱癌復(fù)發(fā)預(yù)測的關(guān)系。方法:1.分離并提取膀胱癌患者尿液外泌體,并通過透射電子顯微鏡、免疫印跡技術(shù)、納米粒徑分析等多種方法鑒定外泌體。2.通過檢索文獻(xiàn)獲得在膀胱癌組織中異常表達(dá)且與膀胱癌的發(fā)生、發(fā)展密切相關(guān)的8個lncRNAs作為候選分子,如下:MALAT1,PCAT-1,SPRY4-IT1,UCA1,MEG3,H19,UBC1 和 TUG1。3.在訓(xùn)練階段,提取104例膀胱癌患者和104例健康對照者尿液外泌體中的RNA,利用實時熒光定量PCR(qRT-PCR)分析上述8個lncRNAs的表達(dá)情況,篩選出在膀胱癌尿液外泌體中異常表達(dá)的lncRNA分子。針對異常表達(dá)的...
【文章來源】:山東大學(xué)山東省 211工程院校 985工程院校 教育部直屬院校
【文章頁數(shù)】:59 頁
【學(xué)位級別】:碩士
【部分圖文】:
圖1:尿液外泌體的特征
圖3:驗證尿液外泌體IncRNA?MALAT1、PCAT-1和SPRY4-IT1的差異表達(dá)趨??勢及其檢測膀胱癌的診斷效能。使用qRT-PCR檢測驗證組膀胱癌患者(n=80)??與健康對照(n=80)中尿液外泌體lncRNA?MALAT1?(a)、PCAT-1?(b)和??SPRY4-IT1?(c)的表達(dá)水平(P<0.001?)。ROC曲線分析顯示尿液外泌體IncRNA??MALAT1?(d)、PCAT-1?(e)和SPRY4-IT1?(f)在驗證組中對膀胱癌的診斷效??能。***表示尸<0.001。??Figure?3.?Validation?of?UE-derived?MALAT1,?PCAT-1?and?SPRY4-IT1?as?biomarkers??for?BC?diagnosis?and?their?diagnostic?performance.?Concentrations?of?UE-derived??MALAT1?(a),?PCAT-1?(b)?and?SPRY4-IT1?(c)?in?BCs?(n=80)?vs.?healthy?controls??(n=80)?using?the?qRT-PCR?assay?in?the?validation?set?(P<0.001).?ROC?curve?analysis??showing?the?diagnostic?performance?for?BC?of?UE-derived?MALAT1?(d),?PCAT-1?(e)??and?SPRY4-IT1?(f)?in?the?validation?set.?***?represents?P?<0.001.??
圖4:尿液外泌體IncRNA的穩(wěn)定性。尿液組和尿液外泌體RNA組分別與RNase??A孵育Omin、30min、60min和90min。RNase?A對尿液組外泌體IncRNA水平無??影響(a-c)。而尿液外泌體RNA組在30?min內(nèi)經(jīng)過RNase?A處理完全降解(d-f)。??尿液樣本在-80°C的環(huán)境存放1個月、2個月和3個月,這種處理方式對尿液外泌??體IncRNA的含量無影響(g-i)。*代表尸<0.05,**代表尸<0.01,***代表尸<0.001。??Figure?4.?Stability?of?UEs.?Urine?group?and?exosome?isolated?nucleic?acids?group??were?incubated?with?RNase?A?for?0,?30,?60,?and?90?minutes,respectively.?RNase?A??had?no?effect?on?the?level?of?exosomal?IncRNAs?in?urine?group?(a-c).?However,??exosome?isolated?nucleic?acids?group?were?completely?degraded?by?the?treatment?of??RNase?A?within?30?min?(d-f).?Urine?samples?were?incubated?at?-80?°C?for?1,?2,?and?3??months,?and?this?treatments?had?no?effect?on?the?level?of?exosomal?IncRNAs?(g-i).*??rep
本文編號:3524928
【文章來源】:山東大學(xué)山東省 211工程院校 985工程院校 教育部直屬院校
【文章頁數(shù)】:59 頁
【學(xué)位級別】:碩士
【部分圖文】:
圖1:尿液外泌體的特征
圖3:驗證尿液外泌體IncRNA?MALAT1、PCAT-1和SPRY4-IT1的差異表達(dá)趨??勢及其檢測膀胱癌的診斷效能。使用qRT-PCR檢測驗證組膀胱癌患者(n=80)??與健康對照(n=80)中尿液外泌體lncRNA?MALAT1?(a)、PCAT-1?(b)和??SPRY4-IT1?(c)的表達(dá)水平(P<0.001?)。ROC曲線分析顯示尿液外泌體IncRNA??MALAT1?(d)、PCAT-1?(e)和SPRY4-IT1?(f)在驗證組中對膀胱癌的診斷效??能。***表示尸<0.001。??Figure?3.?Validation?of?UE-derived?MALAT1,?PCAT-1?and?SPRY4-IT1?as?biomarkers??for?BC?diagnosis?and?their?diagnostic?performance.?Concentrations?of?UE-derived??MALAT1?(a),?PCAT-1?(b)?and?SPRY4-IT1?(c)?in?BCs?(n=80)?vs.?healthy?controls??(n=80)?using?the?qRT-PCR?assay?in?the?validation?set?(P<0.001).?ROC?curve?analysis??showing?the?diagnostic?performance?for?BC?of?UE-derived?MALAT1?(d),?PCAT-1?(e)??and?SPRY4-IT1?(f)?in?the?validation?set.?***?represents?P?<0.001.??
圖4:尿液外泌體IncRNA的穩(wěn)定性。尿液組和尿液外泌體RNA組分別與RNase??A孵育Omin、30min、60min和90min。RNase?A對尿液組外泌體IncRNA水平無??影響(a-c)。而尿液外泌體RNA組在30?min內(nèi)經(jīng)過RNase?A處理完全降解(d-f)。??尿液樣本在-80°C的環(huán)境存放1個月、2個月和3個月,這種處理方式對尿液外泌??體IncRNA的含量無影響(g-i)。*代表尸<0.05,**代表尸<0.01,***代表尸<0.001。??Figure?4.?Stability?of?UEs.?Urine?group?and?exosome?isolated?nucleic?acids?group??were?incubated?with?RNase?A?for?0,?30,?60,?and?90?minutes,respectively.?RNase?A??had?no?effect?on?the?level?of?exosomal?IncRNAs?in?urine?group?(a-c).?However,??exosome?isolated?nucleic?acids?group?were?completely?degraded?by?the?treatment?of??RNase?A?within?30?min?(d-f).?Urine?samples?were?incubated?at?-80?°C?for?1,?2,?and?3??months,?and?this?treatments?had?no?effect?on?the?level?of?exosomal?IncRNAs?(g-i).*??rep
本文編號:3524928
本文鏈接:http://sikaile.net/yixuelunwen/mjlw/3524928.html
最近更新
教材專著